These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29685936)

  • 1. Letter by Clerkin et al Regarding Article, "Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation".
    Clerkin KJ; Farr MA; Mancini DM
    Circulation; 2018 Apr; 137(17):1870-1871. PubMed ID: 29685936
    [No Abstract]   [Full Text] [Related]  

  • 2. Response by Wong et al to Letter Regarding Article, "Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation".
    Wong KL; Smith BH; Kremers WK; Pereira NL
    Circulation; 2018 Apr; 137(17):1872-1873. PubMed ID: 29685937
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation.
    Wong KL; Taner T; Smith BH; Kushwaha SS; Edwards BS; Gandhi MJ; Kremers WK; Daly RC; Pereira NL
    Circulation; 2017 Oct; 136(14):1350-1352. PubMed ID: 28972064
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
    Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
    Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
    J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
    Yamada K; Mawulawde K; Menard MT; Shimizu A; Aretz HT; Choo JK; Allison KS; Slisz JK; Sachs DH; Madsen JC
    J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):709-19. PubMed ID: 10733759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are De Novo DQ Donor-Specific Antibodies the Key to Chronic Lung Allograft Dysfunction?
    Shenoy KV
    Am J Respir Crit Care Med; 2016 Sep; 194(5):534-5. PubMed ID: 27585379
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement (C1q) Binding De Novo Donor-Specific Antibodies and Cardiac-Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Das BB; Lacelle C; Zhang S; Gao A; Fixler D
    Transplantation; 2018 Mar; 102(3):502-509. PubMed ID: 28885488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart transplantation using allografts from older donors: Multicenter study results.
    Roig E; Almenar L; Crespo-Leiro M; Segovia J; Mirabet S; Delgado J; Pérez-Villa F; Luís Lambert J; Teresa Blasco M; Muñiz J;
    J Heart Lung Transplant; 2015 Jun; 34(6):790-6. PubMed ID: 25499140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
    Hodges AM; Lyster H; McDermott A; Rice AJ; Smith JD; Rose ML; Banner NR
    Transplantation; 2012 Mar; 93(6):650-6. PubMed ID: 22245878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
    Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
    Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation.
    Farrero Torres M; Pando MJ; Luo C; Luikart H; Valantine H; Khush K
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28940521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.